US 11254686
Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
granted A61PA61P35/00
Quick answer
US patent 11254686 (Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor) held by Corvus Pharmaceuticals, Inc. expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00